Canada - English - Health Canada

hospira healthcare ulc - trometamol - solution - 36mg - trometamol 36mg - alkalinizing agents

United States - English - NLM (National Library of Medicine)

a-s medication solutions - metaxalone (unii: 1nma9j598y) (metaxalone - unii:1nma9j598y) - metaxalone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. the mode of action of this drug has not been clearly identified, but may be related to its sedative properties. metaxalone does not directly relax tense skeletal muscles in man. known hypersensitivity to any components of this product. known tendency to drug induced, hemolytic, or other anemias. significantly impaired renal or hepatic function.

United States - English - NLM (National Library of Medicine)

glaxosmithkline llc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

United States - English - NLM (National Library of Medicine)

cardinal health - metaxalone (unii: 1nma9j598y) (metaxalone - unii:1nma9j598y) - metaxalone 800 mg

United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 80 mg in 1 ml

United States - English - NLM (National Library of Medicine)

boiron - nickel (unii: 7ov03qg267) (nickel - unii:7ov03qg267) - headache from mental overexertion* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

United States - English - NLM (National Library of Medicine)

l. perrigo company - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - expectorant of bothersome mucus and make coughs more productive

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - simvastatin (unii: agg2fn16ev) (simvastatin - unii:agg2fn16ev) - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with coronary heart disease (chd) or at high risk of chd, simvastatin can be started simultaneously with diet. in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease, simvastatin is indicated to: •    reduce the risk of total mortality by reducing chd deaths. •    reduce the risk of non-fatal myocardial infarction and stroke. •    reduce the need for coronary and non-coronary revascularization procedures. simvastatin is indicated to: •    reduce elevated total cholesterol (total-c), low-de

Australia - English - Department of Health (Therapeutic Goods Administration)

great grand care pty ltd - bupleurum falcatum, quantity: 18.5 mg/g; actaea cimicifuga, quantity: 18.5 mg/g; glycyrrhiza glabra, quantity: 74.1 mg/g; ziziphus jujuba, quantity: 37 mg/g; astragalus membranaceus, quantity: 111.2 mg/g; zingiber officinale, quantity: 55.6 mg/g; angelica polymorpha, quantity: 37 mg/g; panax ginseng, quantity: 74.1 mg/g; atractylodes macrocephala, quantity: 37 mg/g; citrus reticulata, quantity: 37 mg/g (equivalent: oxedrine, qty 0.98 mg/g) - granules - excipient ingredients: potato starch - traditionally used in chinese medicine to harmonise the middle-burner (spleen and stomach) ; traditionally used in chinese medicine to increase/augment/generate/promote/strengthen qi ; traditionally used in chinese medicine to upraise/lift the sunken middle-qi

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 15993 - pacemaker programmer - pacemaker programmer the merlin patient care system model 3650 is intended for use in interrogating and programming implantable cardiac pulse generators and implantable cardiac defibrillators.